Protein Engineering Market Size, Share, Growth, Trends | Report 2023-2032
The global protein engineering market was estimated at USD 2.20 billion in 2022 and it is expected to surpass around USD 10.26 billion by 2032, poised to grow at a CAGR of 16.65% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 2.20 billion |
| Revenue Forecast by 2032 | USD 10.26 billion |
| Growth rate from 2023 to 2032 | CAGR of 16.65% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Agilent Technologies; Bruker Corp.; Thermo Fisher Scientific, Inc.; PerkinElmer, Inc.; Waters Corp.; Bio-Rad Laboratories; Merck KGaA; Danaher Corp.; Genscript Biotech Corp; Amgen Inc. |
The market growth can be attributed to a number of factors, including the increased focus of biotechnology and pharmaceutical businesses on research & development of protein-based therapies due to their advantages over non-protein drugs, including higher cost-effectiveness and better patient outcomes. Similarly, an increase in demand for targeted therapies for the treatment of cancer and autoimmune diseases is driving the adoption of protein engineering. The COVID-19 pandemic has boosted the industry due to applications of protein engineering in the production of COVID-19 vaccines and diagnostics.
A bioluminescent diagnostic kit, for instance, was developed in July 2021 by scientists at the Eindhoven University of Technology in Germany. It can be utilized to determine whether an individual’s immune system is producing antibodies in reaction to the coronavirus. Similarly, it is anticipated that the industry will witness substantial growth during the forecast period as a result of the growth in the number of clinical trials involving protein-based treatments for COVID-19. Furthermore, protein engineering is frequently utilized to overcome drug-related defects and can enhance the affinities and effectiveness of molecules for a variety of purposes, such as cardiovascular repair.
This has resulted in a growing demand for the use of protein engineering instruments for the invention of cutting-edge treatments and has sped up market development.In addition, the growing number of government efforts aiming to improve protein engineering capabilities are predicted to offer significant growth potential for the market. As a result, there is an increase in research activities and programs, the number of funds allocated, and R&D spending in this domain. For instance, Nabla Bio announced the closure of a USD 11 million seed fundraising round in December 2021. With the help of this financing, a platform for AI-first design will be developed for enabling the development of next-generation antibody therapeutics.
In addition, in January 2022, Generate Biomedicines & Amgen confirmed a research partnership contract to develop protein therapies for 5 clinical targets.The demand for protein engineering is further increased by the rising incidence of chronic & lifestyle disorders including diabetes, cardiovascular conditions, and others. Other significant factors anticipated to contribute to the market's revenue growth include the increasing incidence of protein deficiency disorders, such as Protein-Energy Malnutrition (PEM), primarily in low-income countries around the world. With the growth in private and public investments in synthetic biology, and ongoing developments in engineering personalized therapies, the industry is expected to witness substantial growth in the near future.
Protein Engineering Market Segmentations:
| By Product | By Technology | By Protein Type | By End-use |
|
Instruments Reagents Software & Services |
Rational Protein Design Directed Evolution Hybrid Approach De Novo Protein Design Others |
Insulin Monoclonal Antibodies Vaccines Growth Factors Colony Stimulating Factors Coagulation Factors Interferon Others |
Academic Research Institutes Contract Research Organizations Pharmaceutical & Biotechnology Companies |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Protein Engineering Market
5.1. COVID-19 Landscape: Protein Engineering Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Protein Engineering Market, By Product
8.1. Protein Engineering Market, by Product, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Reagents
8.1.2.1. Market Revenue and Forecast (2019-2032)
8.1.3. Software & Services
8.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Protein Engineering Market, By Technology
9.1. Protein Engineering Market, by Technology, 2023-2032
9.1.1. Rational Protein Design
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Directed Evolution
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Hybrid Approach
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. De Novo Protein Design
9.1.4.1. Market Revenue and Forecast (2019-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Protein Engineering Market, By Protein Type
10.1. Protein Engineering Market, by Protein Type, 2023-2032
10.1.1. Insulin
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Monoclonal Antibodies
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Vaccines
10.1.3.1. Market Revenue and Forecast (2019-2032)
10.1.4. Growth Factors
10.1.4.1. Market Revenue and Forecast (2019-2032)
10.1.5. Colony Stimulating Factors
10.1.5.1. Market Revenue and Forecast (2019-2032)
10.1.6. Coagulation Factors
10.1.6.1. Market Revenue and Forecast (2019-2032)
10.1.7. Interferon
10.1.7.1. Market Revenue and Forecast (2019-2032)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Protein Engineering Market, By End-use
11.1. Protein Engineering Market, by End-use, 2023-2032
11.1.1. Academic Research Institutes
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Contract Research Organizations
11.1.2.1. Market Revenue and Forecast (2019-2032)
11.1.3. Pharmaceutical & Biotechnology Companies
11.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Global Protein Engineering Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.2. Market Revenue and Forecast, by Technology (2019-2032)
12.1.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.1.4. Market Revenue and Forecast, by End-use (2019-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.5.2. Market Revenue and Forecast, by Technology (2019-2032)
12.1.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.1.5.4. Market Revenue and Forecast, by End-use (2019-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.6.2. Market Revenue and Forecast, by Technology (2019-2032)
12.1.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.1.6.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.2. Market Revenue and Forecast, by Technology (2019-2032)
12.2.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.2.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.5.2. Market Revenue and Forecast, by Technology (2019-2032)
12.2.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.2.5.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.6.2. Market Revenue and Forecast, by Technology (2019-2032)
12.2.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.2.6.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.7.2. Market Revenue and Forecast, by Technology (2019-2032)
12.2.7.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.2.7.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.8.2. Market Revenue and Forecast, by Technology (2019-2032)
12.2.8.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.2.8.4. Market Revenue and Forecast, by End-use (2019-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.2. Market Revenue and Forecast, by Technology (2019-2032)
12.3.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.3.4. Market Revenue and Forecast, by End-use (2019-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.5.2. Market Revenue and Forecast, by Technology (2019-2032)
12.3.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.3.5.4. Market Revenue and Forecast, by End-use (2019-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.6.2. Market Revenue and Forecast, by Technology (2019-2032)
12.3.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.3.6.4. Market Revenue and Forecast, by End-use (2019-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.7.2. Market Revenue and Forecast, by Technology (2019-2032)
12.3.7.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.3.7.4. Market Revenue and Forecast, by End-use (2019-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.8.2. Market Revenue and Forecast, by Technology (2019-2032)
12.3.8.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.3.8.4. Market Revenue and Forecast, by End-use (2019-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.2. Market Revenue and Forecast, by Technology (2019-2032)
12.4.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.4.4. Market Revenue and Forecast, by End-use (2019-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.5.2. Market Revenue and Forecast, by Technology (2019-2032)
12.4.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.4.5.4. Market Revenue and Forecast, by End-use (2019-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.6.2. Market Revenue and Forecast, by Technology (2019-2032)
12.4.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.4.6.4. Market Revenue and Forecast, by End-use (2019-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.7.2. Market Revenue and Forecast, by Technology (2019-2032)
12.4.7.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.4.7.4. Market Revenue and Forecast, by End-use (2019-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.8.2. Market Revenue and Forecast, by Technology (2019-2032)
12.4.8.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.4.8.4. Market Revenue and Forecast, by End-use (2019-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.2. Market Revenue and Forecast, by Technology (2019-2032)
12.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.5.4. Market Revenue and Forecast, by End-use (2019-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.5.2. Market Revenue and Forecast, by Technology (2019-2032)
12.5.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.5.5.4. Market Revenue and Forecast, by End-use (2019-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.6.2. Market Revenue and Forecast, by Technology (2019-2032)
12.5.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)
12.5.6.4. Market Revenue and Forecast, by End-use (2019-2032)
Chapter 13. Company Profiles
13.1. Agilent Technologies
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bruker Corp.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. PerkinElmer, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Waters Corp.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bio-Rad Laboratories
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Merck KGaA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Danaher Corp.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Genscript Biotech Corp
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Amgen Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers